Cambridge, MA, United States of America

Ruth Hanna

This inventor holds 1 USPTO granted patent. Top assignee: The Broad Institute, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruth Hanna. Retrieved from https://idiyas.com/inventor/ruth-hanna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ruth Hanna: Innovator in CRISPR Technology

Introduction

Ruth Hanna is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of genetic engineering, particularly through her work with CRISPR technology. Her innovative approach has opened new avenues for research and therapeutic applications.

Latest Patents

Ruth Hanna holds a patent for "CRISPR CPF1 direct repeat variants." This invention relates to systems, methods, and compositions associated with Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and its components. The patent describes engineered Cpf1 polynucleotides that can direct the activity of a CRISPR protein to multiple targets using a single crRNA. The guide sequences can target sequences in eukaryotic cells, including both animal and plant cells. Additionally, the invention encompasses methods for developing or designing CRISPR-Cas system-based therapies or therapeutics.

Career Highlights

Ruth Hanna is affiliated with the Broad Institute, Inc., where she collaborates with leading scientists in the field. Her work has been instrumental in advancing the understanding and application of CRISPR technology.

Collaborations

One of her notable collaborators is John G. Doench, with whom she has worked closely on various projects related to CRISPR and genetic engineering.

Conclusion

Ruth Hanna's contributions to CRISPR technology exemplify her innovative spirit and dedication to advancing genetic research. Her work continues to influence the field and pave the way for future developments in gene editing and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…